Market cap
--
$0.03
As on 16-Feb-2022 14:29EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
--
ROE
--
ROCE
--
Industry P/E
--
EV/EBITDA
--
Debt to Equity
--
Book Value
--
EPS
--
Face value
--
Shares outstanding
--
CFO
$-246.86 Mln
EBITDA
$-37,255.04 Mln
Net Profit
$-35,527.86 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Oncobiologics Inc. Series A Warrant (OTLKW)
| -74.4 | -40.0 | -82.9 | -96.6 | -- | -- | -- |
|
BSE Sensex*
| -7.8 | 4.8 | -6.3 | 3.9 | 8.9 | 10.0 | 11.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
--
Headquarters
--
Website
--
The share price of Oncobiologics Inc Series A Warrant (OTLKW) is $0.03 (NASDAQ) as of 16-Feb-2022 14:29 EDT. Oncobiologics Inc Series A Warrant (OTLKW) has given a return of -96.6% in the last 1 years.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
-0.21
|
2.43
|
|
2020
|
0.00
|
2.58
|
|
2019
|
-0.06
|
-0.19
|
|
2018
|
--
|
--
|
|
2017
|
--
|
--
|
The 52-week high and low of Oncobiologics Inc Series A Warrant (OTLKW) are Rs -- and Rs -- as of 16-Apr-2026.
Oncobiologics Inc Series A Warrant (OTLKW) has a market capitalisation of -- as on 03-Mar-2022. As per SEBI classification, it is a company.
Before investing in Oncobiologics Inc Series A Warrant (OTLKW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.